Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

8596	Companies
140052	Keywords
75994	Articles
74784	Press releases

Home
Companies
Moderna, Inc.

BRIEF

published on 03/31/2025 at 13:05, 2 days 17 hours ago

Moderna obtient l'approbation du vaccin contre le VRS en Australie

Moderne Vaccin Contre Le VRS Personnes Âgées Technologie De L'ARNm Approbation De L'Australie
BRIEF

published on 03/31/2025 at 13:05, 2 days 17 hours ago

Moderna Secures Approval for RSV Vaccine in Australia

MRNA Technology Older Adults Moderna RSV Vaccine Australia Approval
PRESS RELEASE

published on 03/31/2025 at 13:00, 2 days 17 hours ago

Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults
Moderna's mRESVIA (mRNA-1345) receives TGA approval in Australia for RSV vaccine in older adults, a milestone in mRNA technology beyond COVID-19 protection

Older Adults Moderna RSV Vaccine MRESVIA TGA Approval
BRIEF

published on 02/28/2025 at 16:35, 1 month 2 days ago

Moderna reçoit l'approbation du Royaume-Uni pour son vaccin contre le VRS mRESVIA®

Moderne Maladies Respiratoires Vaccin Contre Le VRS Technologie De L'ARNm Autorisation Pour Le Royaume-Uni
BRIEF

published on 02/28/2025 at 16:35, 1 month 2 days ago

Moderna Receives UK Approval for RSV Vaccine mRESVIA®

MRNA Technology Moderna RSV Vaccine UK Authorization Respiratory Disease
PRESS RELEASE

published on 02/28/2025 at 16:30, 1 month 2 days ago

Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
Moderna's mRESVIA, an RSV vaccine, receives marketing authorization in the UK for adults 60+ to prevent lower respiratory tract disease by respiratory syncytial virus. Second approved product in the UK

UK Moderna RSV Vaccine MRESVIA Marketing Authorization
BRIEF

published on 02/25/2025 at 13:05, 1 month 5 days ago

Moderna to Participate in March 2025 Investor Conferences

Investor Conferences Healthcare Webcast MRNA Technology Moderna
BRIEF

published on 02/25/2025 at 13:05, 1 month 5 days ago

Moderna participera aux conférences d'investisseurs de mars 2025

Webcast Soins De Santé Conférences D'investisseurs Moderne Technologie De L'ARNm
PRESS RELEASE

published on 02/25/2025 at 13:00, 1 month 5 days ago

Moderna to Present at Upcoming Conferences in March 2025
Moderna, Inc. to participate in investor conferences. Live webcasts available. Leading in mRNA medicine, advancing technology for disease treatment/prevention

Investor Conferences Healthcare COVID-19 Vaccine MRNA Medicine Moderna
BRIEF

published on 02/14/2025 at 12:33, 1 month 16 days ago

Moderna Announces 2024 Financial Results and Future Projections

Cost Reduction Moderna Revenue Projections Financial Results 2024 MRNA Products

Accesswire

Published on 04/03/2025 at 05:10, 1 hour 44 minutes ago

Battery X Metals Announces Corporate Awareness Agreement
Published on 04/03/2025 at 01:35, 5 hours 19 minutes ago

GMV Minerals Inc. Closes Non-Brokered Financing/ Engages Investor Relations Firm
Published on 04/02/2025 at 23:35, 7 hours 19 minutes ago

Murchison Minerals to Seek Shareholders’ Approval for Share Consolidation
Published on 04/02/2025 at 20:00, 10 hours 54 minutes ago

Network-1 Announces Acquisition of Patent Portfolio
Published on 04/02/2025 at 17:25, 13 hours 29 minutes ago

SOBRsafe Announces Reverse Stock Split

View all ACCESSWIRE

EQS Group

Published on 04/03/2025 at 06:40, 13 minutes ago

Ad hoc announcement pursuant to Art. 53 LR: Jungfraubahn Holding AG: Jungfrau Railway Group reports a successful 2024 financial year
Published on 04/02/2025 at 20:20, 10 hours 33 minutes ago

EQS-Adhoc: Siemens Aktiengesellschaft: Siemens acquires Dotmatics to extend AI-powered software portfolio to Life Sciences
Published on 04/02/2025 at 20:01, 10 hours 53 minutes ago

Annual General Meeting of Deutsche Konsum REIT-AG successfully held
Published on 04/02/2025 at 20:01, 10 hours 53 minutes ago

Travis Perkins: Publication of the Annual Report and Accounts 2024
Published on 04/02/2025 at 19:40, 11 hours 13 minutes ago

LION E-Mobility AG starts successfully into the new 2025 financial year – Challenging market environment impacts 2024

Les Echos

Published on 04/03/2025 at 00:37, 6 hours 17 minutes ago

Publication of the report on payments made to governments provided by article L.225-102-3 of the French Commercial Code
Published on 04/03/2025 at 00:37, 6 hours 17 minutes ago

Mise à disposition du rapport sur les paiements faits aux gouvernements prévu à l’article L.225-102-3 du Code de commerce
Published on 04/02/2025 at 18:05, 12 hours 49 minutes ago

Financial statements - 31 december 2024
Published on 04/02/2025 at 17:45, 13 hours 9 minutes ago

Aéroports de Paris SA - Droits de vote au 31 mars 2025
Published on 04/02/2025 at 17:45, 13 hours 9 minutes ago

Aéroports de Paris SA - Voting rights as of 31 March 2025

View all LES ECHOS COMFI WIRE